Pharmacoeconomic Analysis of the Diabetes Initiative Program: A Pharmacist-Physician Collaborative Care Model

Annals of Pharmacotherapy

Volumn 47, Issue 12, 2013, Pages 1627-1634

  Franklin, Brandi E ^a   Farland, Michelle Z ^a   Thomas, Jeremy ^b   McFarland, M Shawn ^c   Ray, Shaunta' M ^a   Byrd, Debbie C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

clinical pharmacy; collaborative care; diabetes; pharmacist; pharmacoeconomics

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

CLINICAL PHARMACY; COLLABORATIVE CARE; DIABETES; PHARMACIST; PHARMACOECONOMICS;

BLOOD PRESSURE; COOPERATIVE BEHAVIOR; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION THERAPY MANAGEMENT; PATIENT CARE TEAM; PHARMACISTS; PHYSICIANS;

EID: 84891723891     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013506883     Document Type: Article

References (15)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033-1046. doi:10.2337/dcl12-2625. http://care.diabetesjournals.org/content/36/4/1033.full.pdf+html. Accessed May 9, 2013.
2. Altavela JL,Jones MK,Ritter M.A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.J Manag Care Pharm. 2008;14:831-843.
3. Yu J,Shah BM,Ip EJ,Chan J.A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.J Manag Care Pharm. 2013;19:102-114.
4. Wubben DP,Vivian EM.Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review.Pharmacotherapy. 2008;28:421-436.
5. Rothman RL,So SA,Shin Jet al.Labor characteristics and program costs of a successful diabetes disease management program.Am J Manag Care. 2006;12:277-283.
6. Farland MZ,Byrd DC,McFarland MSet al.Pharmacist-physician collaboration for diabetes care: the diabetes initiative program.Ann Pharmacother. 2013;47:781-789.
7. Pharmacist Services Technical Advisory Coalition. Medication therapy management service codes. http://www.pstac.org/services/mtms-codes.html. Accessed March 5, 2013.
8. Bureau of Labor Statistics. Occupational employment statistics: occupational employment and wages, May2011. http://www.bls.gov/oes/current/oes291051.htm. Accessed March 5, 2013.
9. Wagner EH,Sandhu N,Newton KM,McCulloch DK,Ramsey SD,Grothaus LC.Effect of improved glycemic control on health care costs and utilization.JAMA. 2001;285:182-189.
10. Houle SKD,Chuck AW,McAlister A,Tsuyuki RT.Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the study of cardiovascular risk intervention by pharmacists: hypertension.Pharmacotherapy. 2012;32:527-537.
11. Carter BL,Doucette WR,Franciscus CL,Ardery G,Kluesner KM,Chrischilles EA.Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.Pharmacotherapy. 2010;30:228-235.
12. McFarland M,Davis K,Wallace Jet al.Use of home telehealth monitoring with active medication management by clinical pharmacist in veterans with poorly controlled type 2 diabetes.Pharmacotherapy. 2012;32:420-426.
13. Cranor CW,Bunting BA,Christensen DB.The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.J Am Pharm Assoc. 2003;43:173-184.
14. Fera T,Bluml BM,Ellis WM.Diabetes Ten City Challenge: final economic and clinical results.J Am Pharm Assoc. 2009;49:383-391.
15. GibersonSYoderSLeeMP. Improving patient and health system outcomes through advanced pharmacy practice: a report to the U.S. Surgeon General. http://www.usphs.gov/corpslinks/pharmacy/documents/2011AdvancedPharmacyPracticeReporttotheUSSG.pdf. Accessed September 18, 2013.